Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
McKinsey
Dow
Merck
Baxter

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Pfizer Inc v. Teva Pharmaceuticals USA (D. Del. 2006)

See Plans and Pricing

« Back to Dashboard

Pfizer Inc v. Teva Pharmaceuticals USA (D. Del. 2006)

Docket   Start Trial Date Filed 2006-02-08
Court District Court, D. Delaware Date Terminated 2006-11-28
Cause 35:271 Patent Infringement Assigned To Joseph James Farnan Jr.
Jury Demand Defendant Referred To
Parties PFIZER INC; TEVA PHARMACEUTICALS INDUSTRIES, LTD.; TEVA PHARMACEUTICALS USA
Patents 4,895,726; 5,889,015; 6,068,859; 6,248,741; 6,268,489; 6,465,464
Attorneys Daniel Christopher Mulveny; Mary Matterer; Richard D. Kirk; Rudolf E. Hutz
Firms Kessler Topaz Meltzer Check LLP; Novak Druce Connolly Bove Quigg LLP, the Nemours Building
Link to Docket External link to docket
Small Molecule Drugs cited in Pfizer Inc v. Teva Pharmaceuticals USA
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Pfizer Inc v. Teva Pharmaceuticals USA (D. Del. 2006)

Date Filed Document No. Description Snippet Link To Document
2006-02-23 13 Declaration administration of anithromye'in; U.S. Pat. No. 6,|]68,859 which claims a controlled dosage form containing…infringement of U.S. Patent Nos. 5,605,889 (the “’889 patent”) and 6,268,489 (the “’489 patent”). Attached hereto…United Sfates_ Patent 1191 11 n Patent Nnmber: 5,605,889 Curawlo et at. 1451 Date ot Patent: Feb. 25, 1997…United Sfalf€S Patent (m) Patent No.: US 6,268,489 Bl Alleo et al. (45) Date of Patent: .[nl. 31, 2001…ttttttttittttt United Stat€$ Patent [w| [tt] Patent Number: 5,605,889 1451-flats of Patent:_ _ Feh. 25, 102 Curatolo External link to document
2006-03-09 18 Answering Brief in Opposition 5, Ex. D) and 6,268,489 (“the ‘489 patent”; Mnlveny Decl. at ll 5, Ex. E}, were infringed by Teva’s ANDA… the ‘243 patent B. The Delaware Action Invo}ves a Patent That is Unrelated to the Patents at Issne in…asserting that the two involved patents, U.S. Patent Nos. 5,6()5,889 (“the ’889 patent”; Mnlveny Decl. at il 5…basis for this case is patent infringement of the ‘243 patent, not unrelated patents that 'l`eva placed…464 Patent"). The `464 Patent is based on a continuation application of two Allergan patents asserted External link to document
2006-03-09 19 Declaration Federal Circuit construing the claims ofU.S. Patent 4,895,726 ("the "726 patcnt) and holding that…unreiated patents, U.S. Patent Nos. 5,605,889 (“the ‘889 patent”) and 6,268,489 {“the ‘489 patent”). A true… of U.S, Patents Nos. 4,895,?26 (the “".726 patent”), 6,{)7'4,670 (the “’670 patent”), and 6,…the disputed patents, the prosecution ol` the patents, the record considered by the Patent Oifice in issuing…of the ‘889 patent attached hereto as Exhibit D. A true and correct copy of the ‘489 patent attached hereto External link to document
2006-03-09 20 Declaration infi‘inge Piizer’s U.S. Patent Nos. 5,605,889 (“the ‘889 patent”) and 6,268,489 Case 1:06-cv-00089-JJF… 03/09/2006 Page 2 of 4 (“the ‘489 patent”), and that the patents are invalid Teva tiled a second complaint…counterclaims asserting that the ‘889 patent and the ‘489 patent were infi'inged, pursuant to 35 U.S.C…regarding the ‘889 patent, and thus Teva did not pursue its claims regarding that patent On June 20, 2005… invalidity of the ‘489 patent, as well as a deciaration that the ‘489 patent is unenforceable due to External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Harvard Business School
Boehringer Ingelheim
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.